MedTrace Logo

A Study of the Effects of Lavender Aromatherapy on Preoperative Anxiety in Breast Surgery Patients

NCT03445130 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2022-02-18

No results posted yet for this study

Summary

The purpose of this study is to determine the effects of lavender aromatherapy on preoperative anxiety by measuring changes in pulse rate and anxiety core using Spielberger State-Trait Anxiety Index questionnaires and on postoperative pain medicine usage. Study participants will then be randomized into one of four groups; either they will receive 2 drops of lavender (Lavandula Angustifolia) oil (LO) or 2 drops of Michelia Alba Leaf oil (MA) or 2 drops of unscented Almond oil (AO) or two drops water on the inside of an oxygen face mask for 15 minutes. Linalool makes up \~30% of Lavandula Angustifolia oil and is believed to be its most active anti-anxiety component. Before and after treatment, anxiety level will be measured using the Spielberger State-Trait Anxiety Inventory.

Conditions

Interventions

OTHER

Lavandula Angustifolia oil (LO)

two drops on the inside of an oxygen face mask for 15 minutes.

OTHER

Michelia Alba Leaf oil (MA)

two drops on the inside of an oxygen face mask for 15 minutes.

OTHER

Almond oil (AO)

two drops on the inside of an oxygen face mask for 15 minutes.

OTHER

Water

two drops on the inside of an oxygen face mask for 15 minutes.

Sponsors & Collaborators

Principal Investigators

  • Michael Wajda, MD · New York Langone Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-10
Primary Completion
2020-09-23
Completion
2020-09-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03445130 on ClinicalTrials.gov